Health
Pfizer Goes It Alone to Expand Vaccine Business Beyond Covid-19 Pandemic – The Wall Street Journal
CEO Albert Bourla says company will use gene-based technology learned by working with Germany’s BioNTech to tackle other diseases
Pfizer Inc. aims to expand its vaccine business by becoming a leader in the new gene-based technology behind its successful Covid-19 shots.
Pfizer will develop new shots using the technology, called mRNA, to target other viruses and pathogens beyond the coronavirus, Chief Executive Albert Bourla said in an interview. He said the companys scientists and engineers gained a decades worth of experience in the past year working on the Covid-19 vaccine with Germanys BioNTech SE , and is ready to pursue…
-
Noosa News16 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
Noosa News18 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
General15 hours agoPostecoglou’s message touches Blues AFL coach Voss after Spurs’ Europa League win
-
General22 hours agoOne person dead after house fire in Melbourne’s south-east